Inselspital Bern
Bern, Switzerland
Location status: Recruiting
NCT Number: NCT03024671
The dermatological testing of cosmetic products which are new on the market, or existing products with novel formulations is common and a useful procedure, yet necessary to alleviate common irritants and contact allergic reactions. Cosmetic products contain a range of substances that may be considered as potential irritants or contact allergens. In order to estimate that risk, cosmetics are tested by applying patch tests.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Bern, Switzerland
Location status: Recruiting
The dermatological testing of cosmetic products which are new on the market, or existing products with novel formulations is common and a useful procedure, yet necessary to alleviate common irritants and contact allergic reactions. Cosmetic products contain a range of substances that may be considered as potential irritants or contact allergens. In order to estimate that risk, cosmetics are tested by applying patch tests, as with allergic reactions.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
test patch with cosmetic product will be applied to the back
Time frame: 4 weeks
Inflammation of Skin at test patch location
Contact information is provided by the study sponsor or research team.
Insel Gruppe AG, University Hospital Bern
Other
Epicutaneous Testing of Cosmetic Products to Determine Skin Compatibility
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01631617
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis
Bethesda, Maryland, United States
View Trial DetailsNCT07599813
Atopic, Atopic Dermatitis
Birmingham, Alabama, United States
View Trial DetailsNCT07414602
Dermatitis, Skin Diseases
Chengdu, Sichuan, China
View Trial DetailsNCT05611346
Dermatitis, Skin Diseases
Saint-Denis, Reunion
View Trial Details